Eiken Chemical has resolved to oppose the shareholder proposal as a Board of Directors. The proposal concerns the appointment of two directors, citing concerns over independence and potential conflicts of interest. The review of management strategies and medium-term plans has been separately disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4549","jir_company_name":"Eiken Chemical Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-05-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4549-20260512-06.pdf","jir_short_summary":"Eiken Chemical has resolved to oppose the shareholder proposal as a Board of Directors. The proposal concerns the appointment of two directors, citing concerns over independence and potential conflicts of interest. The review of management strategies and medium-term plans has been separately disclosed.","jir_summary":"### Board of Directors' Opinion on the Shareholder Proposal\nEiken Chemical received a proposal from shareholders on April 14, 2026, to appoint two directors, and the Board of Directors resolved to oppose it. The proposer is affiliated with Dalton Advisory, and concerns over independence and conflicts of interest are cited. The Board of Directors considers that the proposed candidates do not meet the company's independence standards and could harm shareholder interests.\n\n### Future Management Policies and Corporate Strategies\nEiken Chemical announced a new management plan in April 2026, aiming for sustainable growth and enhancement of corporate value. The medium-term management plan focuses on expanding high-value-added sectors and strengthening overseas operations, with proactive consideration of alliances and M&A. The Board of Directors has determined that the current management structure and the appointment of candidates will maintain optimal governance.","jir_financial_highlights":"","jir_category":"","jir_hashtags":"#EikenChemical, #IRRelatedCategory, #JapanStocks","jir_key_figures":"Shareholder Proposal Holder's Shareholding Ratio: 32.84%\nDalton Advisory's Shareholding Ratio: 19.75%\nNumber of Shares Held by Proposed Candidate: 0 shares","jir_meta_title":"\u3010Eiken Chemical\u3011Opposition to Shareholder Proposal\uff5cMay 2026","jir_meta_description":"Eiken Chemical's Board of Directors opposes the shareholder proposal. Detailed explanation of the proposal content, reasons, and future management policies.","jir_og_title":"\u3010Eiken Chemical\u3011Opposition to Shareholder Proposal\uff5cMay 2026","jir_og_description":"Eiken Chemical has resolved to oppose the shareholder proposal. Details on management strategies and future plans.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16754,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-46890","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n